Literature DB >> 21093559

Preparation of a chemically stable quercetin formulation using nanosuspension technology.

Lei Gao1, Guiyang Liu, Xiaoqing Wang, Fei Liu, Yuefang Xu, Jing Ma.   

Abstract

In the present study the evaporative precipitation into aqueous solution (EPAS) process and the high homogenization press (HPH) process were compared to evaluate their feasibility to form a chemically stable quercetin nanosuspension. The particle size and Zeta potential of the EPAS nanosuspension were similar to those of the HPH nanosuspension. Differences in results of differential scanning calorimetery and X-ray measures were observed between the two processes. The crystalline-to-amorphous phase transition was shown in the profile of EPAS dried powder. On the contrary the initial crystalline state of drug was maintained throughout the HPH process. Dissolution test results indicated that the EPAS process showed a higher improvement in the drug solubility and dissolution rate than the HPH process. At last the high performance liquid chromatography (HPLC) analysis proved the superiority of both nanosuspensions over QCT solution formulation for the chemical and photo-stability. As a result, it can be concluded that the EPAS and HPH techniques were feasible to prepare a chemically stable QCT nanosuspension with significantly enhanced dissolution rate.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21093559     DOI: 10.1016/j.ijpharm.2010.11.009

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  21 in total

1.  Development of quercetin nanoformulation and in vivo evaluation using streptozotocin induced diabetic rat model.

Authors:  Deepak Chitkara; Sanjay K Nikalaje; Anupama Mittal; Mahesh Chand; Neeraj Kumar
Journal:  Drug Deliv Transl Res       Date:  2012-04       Impact factor: 4.617

Review 2.  Nanocarriers for vascular delivery of antioxidants.

Authors:  Elizabeth Hood; Eric Simone; Paritosh Wattamwar; Thomas Dziubla; Vladimir Muzykantov
Journal:  Nanomedicine (Lond)       Date:  2011-09       Impact factor: 5.307

Review 3.  Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs.

Authors:  Lei Gao; Guiyang Liu; Jianli Ma; Xiaoqing Wang; Liang Zhou; Xiang Li; Fang Wang
Journal:  Pharm Res       Date:  2012-10-17       Impact factor: 4.200

4.  Nanocrystals for the parenteral delivery of poorly water-soluble drugs.

Authors:  Bo Sun; Yoon Yeo
Journal:  Curr Opin Solid State Mater Sci       Date:  2012-12-01       Impact factor: 11.354

5.  Elucidating the in vivo fate of nanocrystals using a physiologically based pharmacokinetic model: a case study with the anticancer agent SNX-2112.

Authors:  Dong Dong; Xiao Wang; Huailing Wang; Xingwang Zhang; Yifei Wang; Baojian Wu
Journal:  Int J Nanomedicine       Date:  2015-03-31

6.  Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study.

Authors:  Francesco Di Pierro; Giuseppe Derosa; Pamela Maffioli; Alexander Bertuccioli; Stefano Togni; Antonella Riva; Pietro Allegrini; Amjad Khan; Saeed Khan; Bilal Ahmad Khan; Naireen Altaf; Maria Zahid; Ikram Din Ujjan; Roohi Nigar; Mehwish Imam Khushk; Maryam Phulpoto; Amanullah Lail; Bikha Ram Devrajani; Sagheer Ahmed
Journal:  Int J Gen Med       Date:  2021-06-08

7.  Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial.

Authors:  Francesco Di Pierro; Somia Iqtadar; Amjad Khan; Sami Ullah Mumtaz; Mohsin Masud Chaudhry; Alexander Bertuccioli; Giuseppe Derosa; Pamela Maffioli; Stefano Togni; Antonella Riva; Pietro Allegrini; Saeed Khan
Journal:  Int J Gen Med       Date:  2021-06-24

Review 8.  A Critical Appraisal of Solubility Enhancement Techniques of Polyphenols.

Authors:  Harkiran Kaur; Gurpreet Kaur
Journal:  J Pharm (Cairo)       Date:  2014-03-03

9.  Efavirenz dissolution enhancement I: co-micronization.

Authors:  Maíra Assis da Costa; Rafael Cardoso Seiceira; Carlos Rangel Rodrigues; Cristiane Rodrigues Drago Hoffmeister; Lucio Mendes Cabral; Helvécio Vinícius Antunes Rocha
Journal:  Pharmaceutics       Date:  2012-12-20       Impact factor: 6.321

10.  Design and evaluation of a novel flavonoid-based radioprotective agent utilizing monoglucosyl rutin.

Authors:  Yasushi Aizawa; Shigeaki Sunada; Hirokazu Hirakawa; Akira Fujimori; Takamitsu A Kato; Mitsuru Uesaka
Journal:  J Radiat Res       Date:  2018-05-01       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.